Status:
RECRUITING
Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
Lead Sponsor:
ART Fertility Clinics LLC
Conditions:
Ovarian Stimulation
Eligibility:
FEMALE
18-39 years
Brief Summary
This study examines if monitoring serum Follicle Stimulation Hormone (FSH) levels can predict oocyte yield and progesterone levels, considering factors like age, baseline FSH, Antral Mullerian Hormone...
Detailed Description
Ovarian stimulation typically uses transvaginal ultrasound to monitor follicle growth and endometrial condition, with some clinics also tracking serum estradiol and progesterone levels, but often negl...
Eligibility Criteria
Inclusion
- regular 21 - 35 days cycles
- BMI between 19 - 30 kg/m2
- serum AMH level between 1.5 to 3 ng/ml
- a total antral follicle count between 10 to 24
- endogenous early follicular phase serum FSH level \<10 IU/L
- normal glomerular filtration rate
Exclusion
- hypogonadotropic hypogonadism
- history of ovarian surgery
- permanent ovarian cysts of any form
- older than 39 years
- abnormal thyroid stimulating hormone (TSH)
- renal disease
- elevated prolactin levels
- intake of oral contraceptives 3 months before stimulation start and estradiol pretreatment will be excluded
Key Trial Info
Start Date :
December 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06572930
Start Date
December 16 2024
End Date
December 1 2025
Last Update
February 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ART Fertility Clinics
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 60202